Associate Professor of Medicine, Ohio State University
Endocrinology
Dr. Kathleen M. Dungan, MD
|
|
Give Review
Kathleen Dungan practices Endocrinology. She went to medical school at The Ohio State University College of Medicine. She received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Kathleen M. Dungan is a published physician. She has 36 publications published. The most current publication "Hyperglycemia in patients with hematologic malignancies." Doctor Kathleen M. Dungan, MD accepts all Medicare patients.
Publications
- Hyperglycemia in patients With hematologic malignancies.
- Monitoring Glycemia in Diabetes.
- GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.
- An individualized inpatient Diabetes education and hospital transition program for poorly controlled hospitalized patients with Diabetes.
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 Diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority ...
- A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 Diabetes and congestive heart failure exacerbation.
- A clinician's guide to the treatment of foot burns occurring in Diabetic patients.
- The effect of congestive heart failure on sensor accuracy among hospitalized patients with type 2 Diabetes.
- Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Type 2 Diabetes.
- Pathways to quality inpatient management of hyperglycemia and Diabetes: a call to action.
- Inpatient Diabetes Education Is Associated With Less Frequent Hospital Readmission Among Patients With Poor Glycemic Control.
- Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with Diabetes.
- The effect of Diabetes on hospital readmissions.
- Glycemic variability and glycemic control in the acutely ill cardiac patient.
- Predicting outcomes and assessing control With alternate glycemic markers.
- Clinical outcomes associated With referral-based continuous glucose monitoring using a central standardized interpretation strategy.
- Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients With heart failure or severe hyperglycemia.
- Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 Diabetes and suboptimal control with oral antidiabetic drugs.
- The Effect of Glycemic Variability on Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents with Type 1 Diabetes.
- Concomitant Oral Antihyperglycemic Agent Use is Associated With Treatment Outcomes after Insulin Initiation.
- Relationship between glycemic control and readmission rates in patients hospitalized With congestive heart failure during implementation of hospital-wide initiatives.
- Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 Diabetes.
- 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with Diabetes.
- Expression and biological effect of urodele fibroblast growth factor 1: relationship to limb regeneration.
- Effects of therapy in type 1 and type 2 Diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).
- The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized With congestive heart failure.
- Stress hyperglycaemia.
- A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 Diabetes.
- 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
- Clinical experience With continuous glucose monitoring in adults.
- Glucose variability and mortality in patients With sepsis.
- Glucose measurement: confounding issues in setting targets for inpatient management.
- Comparison of 3 algorithms for Basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery.
- Differential response between Diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery pa...
- Endothelial dysfunction: associations With exposure to ambient fine particles in diabetic individuals.
Schools
Ohio State University College Of Medicine and Public Health
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Diabetes Type 1
- Diabetes Type 2
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of North Carolina Hospitals -
The Ohio State University College of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1598795098 | |
| NPPES Provider LastName | DUNGAN | |
| NPPES Provider FirstName | KATHLEEN | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 807.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598795098 |
| Last Name Of The Provider | DUNGAN |
| First Name Of The Provider | KATHLEEN |
| View All |
Similar Doctors
|
Dr. Mortimer Dolman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John N. Larrimer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dara P. Schuster, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. William B. Malarkey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Leslie K. Hoffman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rundsarah M. Tahboub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fadi A. Nabhan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michelle A. Kovalaske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria J. Henwood-Finley, DO |
|
Dr. Raheela A. Khawaja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aruna A. Suresh, MD
This Doctor is OpenDoctor Recommended.
|